Novice GSK: Farmacevtski velikan išče prevzeme ob vstopu v leto 2023

RAZISKOVALNI TRIKOTNI PARK – GSK is on the prowl for more acquisitions in 2023, a senior executive tells The Financial Times.

“GSK on hunt for attractive biotechs ‘hiding in plain sight,” The FT reports.

“Chief commercial officer Luke Miels looking at targets worth up to $2.5bn,” the paper adds.

Read the full story at: https://www.ft.com/content/16017258-368d-49eb-8555-4603a63b6726